These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28594295)

  • 21. Profile of HIV-infected patients receiving second-line antiretroviral therapy in a resource-limited setting in Nigeria.
    Onyedum CC; Iroezindu MO; Chukwuka CJ; Anyaene CE; Obi FI; Young EE
    Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):608-14. PubMed ID: 23959002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targets for intervention to improve virological outcomes for patients receiving free antiretroviral therapy in Tamil Nadu, India.
    McMahon JH; Manoharan A; Wanke C; Mammen S; Jose H; Malini T; Kadavanu T; Jordan MR; Elliott JH; Lewin SR; Mathai D
    AIDS Care; 2014; 26(5):559-66. PubMed ID: 24125035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohort.
    Hawkins C; Hertzmark E; Spiegelman D; Muya A; Ulenga N; Kim S; Khudyakov P; Christian B; Sando D; Aris E; Fawzi W
    J Antimicrob Chemother; 2017 Jul; 72(7):2060-2068. PubMed ID: 28387836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are death and loss to follow-up still high in people living with HIV on ART after national scale-up and earlier treatment initiation? A large cohort study in government hospital-based setting, Myanmar: 2013-2016.
    Aung ZZ; Oo MM; Tripathy JP; Kyaw NTT; Hone S; Oo HN; Majumdar SS
    PLoS One; 2018; 13(9):e0204550. PubMed ID: 30252904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
    Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
    PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India.
    Gill N; Van den Bergh R; Wut Yee Kyaw K; Laxmeshwar C; Das M; Rastogi S; Arago Galindo M; Mansoor H; Kalon S; Isaakidis P
    PLoS One; 2019; 14(11):e0225631. PubMed ID: 31751433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria.
    Meloni ST; Chang CA; Eisen G; Jolayemi T; Banigbe B; Okonkwo PI; Kanki PJ
    PLoS One; 2016; 11(10):e0164030. PubMed ID: 27764094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low mother-to-child HIV transmission rate but high loss-to-follow-up among mothers and babies in Mandalay, Myanmar; a cohort study.
    Kyaw KWY; Oo MM; Kyaw NTT; Phyo KH; Aung TK; Mya T; Aung N; Oo HN; Isaakidis P
    PLoS One; 2017; 12(9):e0184426. PubMed ID: 28886165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virological outcomes of antiretroviral therapy in Zomba central prison, Malawi; a cross-sectional study.
    Mpawa H; Kwekwesa A; Amberbir A; Garone D; Divala OH; Kawalazira G; van Schoor V; Ndindi H; van Oosterhout JJ
    J Int AIDS Soc; 2017 Aug; 20(1):21623. PubMed ID: 28782332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zimbabwe's national third-line antiretroviral therapy program: Cohort description and treatment outcomes.
    Chimbetete C; Shamu T; Keiser O
    PLoS One; 2020; 15(3):e0228601. PubMed ID: 32119663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure.
    Boerma RS; Bunupuradah T; Dow D; Fokam J; Kariminia A; Lehman D; Kityo C; Musiime V; Palumbo P; Schoffelen A; Sophan S; Zanoni B; Rinke de Wit TF; Calis JCJ; Sigaloff KCE;
    J Int AIDS Soc; 2017 Sep; 20(1):21930. PubMed ID: 28953325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment outcomes of over 1000 patients on second-line, protease inhibitor-based antiretroviral therapy from four public-sector HIV treatment facilities across Johannesburg, South Africa.
    Shearer K; Evans D; Moyo F; Rohr JK; Berhanu R; Van Den Berg L; Long L; Sanne I; Fox MP
    Trop Med Int Health; 2017 Feb; 22(2):221-231. PubMed ID: 27797443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis.
    Minn AC; Kyaw NTT; Aung TK; Mon OM; Htun T; Oo MM; Moe J; Mon AA; Satyanarayana S; Oo HN
    Glob Health Action; 2018; 11(1):1510593. PubMed ID: 30191749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
    Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
    BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of patients on second line antiretroviral therapy under programmatic condition in India.
    Chakravarty J; Sundar S; Chourasia A; Singh PN; Kurle S; Tripathy SP; Chaturbhuj DN; Rai M; Agarwal AK; Mishra RN; Paranjape RS
    BMC Infect Dis; 2015 Nov; 15():517. PubMed ID: 26572102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of virological failure after 1 year's antiretroviral therapy in Vietnamese people with HIV: findings from a retrospective cohort of 13 outpatient clinics in six provinces.
    Tran DA; Wilson DP; Shakeshaft A; Ngo AD; Doran C; Zhang L
    Sex Transm Infect; 2014 Nov; 90(7):538-44. PubMed ID: 24619575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.
    Humphreys EH; Chang LW; Harris J
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006517. PubMed ID: 20556768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virological Outcome of Patients With HIV Drug Resistance Attending an Urban Outpatient Clinic in Uganda: A Need for Structured Adherence Counseling and Third-Line Treatment Options.
    Baumann A; Musaazi J; Kambugu A; Kälin M; Weissberg D; Ssemwanga D; Fehr J; Castelnuovo B; Sekaggya-Wiltshire C; von Braun A
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):481-487. PubMed ID: 30633041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of antiretroviral therapy in an adult HIV program: a 10-year retrospective cohort study in Kano, Nigeria.
    Musa BM; Coker M; Bussell S; Aliyu M; Babashani M; Muhammad H; Nashabaru I; Garbati M
    Ann Saudi Med; 2015; 35(4):303-11. PubMed ID: 26497711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.